Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-22-002407
Filing Date
2022-03-01
Accepted
2022-02-28 18:34:05
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20220228xs3.htm S-3 486290
2 EX-4.3 tmb-20220228xex4d3.htm EX-4.3 430905
3 EX-4.5 tmb-20220228xex4d5.htm EX-4.5 186372
4 EX-4.6 tmb-20220228xex4d6.htm EX-4.6 175095
5 EX-4.7 tmb-20220228xex4d7.htm EX-4.7 165348
6 EX-5.1 tmb-20220228xex5d1.htm EX-5.1 32251
7 EX-23.1 tmb-20220228xex23d1.htm EX-23.1 2608
8 EX-FILING FEES tmb-20220228xexfilingfees.htm EX-FILING FEES 49296
9 GRAPHIC tmb-20220228xs3001.jpg GRAPHIC 11408
10 GRAPHIC tmb-20220228xex5d1001.jpg GRAPHIC 4113
  Complete submission text file 0001558370-22-002407.txt   1550824
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263117 | Film No.: 22692573
SIC: 2834 Pharmaceutical Preparations